HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoei-Sheng Lee Selected Research

thaliporphine

12/2010Thaliporphine ameliorates cardiac depression in endotoxemic rats through attenuating TLR4 signaling in the downstream of TAK-1 phosphorylation and NF-κB signaling.
10/2006Antihyperglycemic effect of aporphines and their derivatives in normal and diabetic rats.
1/2005Thaliporphine increases survival rate and attenuates multiple organ injury in LPS-induced endotoxaemia.
1/2005Attenuation of post-ischemia reperfusion injury by thaliporphine and morphine in rat hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shoei-Sheng Lee Research Topics

Disease

4Neoplasms (Cancer)
12/2023 - 01/2010
2Prostatic Neoplasms (Prostate Cancer)
11/2015 - 01/2012
2Reperfusion Injury
05/2015 - 01/2005
2Infarction (Infarctions)
05/2015 - 01/2005
2Myocardial Ischemia (Ischemic Heart Diseases)
05/2015 - 01/2005
2Type 2 Diabetes Mellitus (MODY)
06/2013 - 10/2006
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2013 - 10/2006
2Hepatocellular Carcinoma (Hepatoma)
01/2012 - 01/2010
2Shock
12/2010 - 01/2005
2Endotoxemia
12/2010 - 03/2006
2Hypotension (Low Blood Pressure)
03/2006 - 01/2005
1Infections
01/2015
1Insulin Resistance
06/2012
1Neoplasm Metastasis (Metastasis)
01/2012
1Renal Cell Carcinoma (Grawitz Tumor)
01/2012
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
04/2010
1Hypoglycemia (Reactive Hypoglycemia)
03/2006
1Acute Kidney Injury (Acute Renal Failure)
03/2006
1Septic Shock (Toxic Shock Syndrome)
03/2006
1Sepsis (Septicemia)
03/2006
1Necrosis
01/2005
1Ischemia
01/2005
1Tachycardia (Tachyarrhythmias)
01/2005

Drug/Important Bio-Agent (IBA)

4thaliporphineIBA
12/2010 - 01/2005
3Hypoglycemic Agents (Hypoglycemics)IBA
06/2013 - 10/2006
2Streptozocin (Streptozotocin)FDA Link
06/2013 - 10/2006
2EndotoxinsIBA
12/2010 - 01/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2006 - 01/2005
1AlkaloidsIBA
12/2023
1TubulinIBA
11/2015
1zerumboneIBA
11/2015
1Hormones (Hormone)IBA
11/2015
1SesquiterpenesIBA
11/2015
11,10- dimethoxy- 6- (2- (2- methoxyphenoxy)ethyl)- 5,6,6a,7- tetrahydro- 4H- dibenzol(de,g)quinoline- 2,9- diy1 bis(dihydrogen phosphate)IBA
05/2015
1salicylhydroxamic acid (SHAM)IBA
05/2015
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2015
1Insulin (Novolin)FDA Link
06/2013
1Glucose (Dextrose)FDA LinkGeneric
06/2012
1borapetoside CIBA
06/2012
1FlavanonesIBA
01/2012
1propolin CIBA
01/2012
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2012
1nymphaeol CIBA
01/2012
1Propolis (Bee Bread)IBA
01/2012
13-nitrotyrosineIBA
12/2010
1Histone Deacetylases (Histone Deacetylase)IBA
04/2010
1VorinostatFDA Link
04/2010
1Histone Deacetylase InhibitorsIBA
04/2010
1Sorafenib (BAY 43-9006)FDA Link
01/2010
1Bortezomib (Velcade)FDA Link
01/2010
1Niacinamide (Nicotinamide)FDA LinkGeneric
10/2006
1AporphinesIBA
10/2006
1N-allylsecoboldineIBA
03/2006
1NitratesIBA
03/2006
1PotassiumIBA
03/2006
1EnzymesIBA
03/2006
1CytokinesIBA
03/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2006
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2005
1Opioid Receptors (Opioid Receptor)IBA
01/2005
1Morphine (MS Contin)FDA LinkGeneric
01/2005
1LipopolysaccharidesIBA
01/2005
1Blood Glucose (Blood Sugar)IBA
01/2005
1AntioxidantsIBA
01/2005

Therapy/Procedure

2Therapeutics
05/2015 - 04/2010